Williams RL, Hyams C, Robertshaw J, Garcia Gonzalez M, Szasz-Benczur Z, White P, Maskell NA, Finn A, Barratt SL. Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration https://www.resmedjournal.com/article/S0954-6111(23)00108-7/fulltext Respiratory Medicine, Volume 0, Issue 0, 107220. https://doi.org/10.1016/j.rmed.2023.107220

Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases | BJGP Open  

TSpeirs, NTuffin, FMundy-Baird, H Sakota, SMulholland, MWestlake, MLyon, A R Medford, ... BJGP Open 2021; 5 (6): BJGPO.2021.0083. DOI: https://doi.org/10.3399/BJGPO.2021.0083  

Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study | BMJ Open Respiratory Research  

Barratt SL, Creamer AW, Adamali HI, Duckworth A, Fallon J, Fidan S, Nancarrow T,… BMJ Open Respir Res. 2021 Nov;8(1):e001063. doi: 10.1136/bmjresp-2021-001063. 

Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review | ScienceGate 

Hardacre CJ, Robertshaw JA, Barratt SL, Adams HL, MacKenzie Ross RV, Robinson GR Br J Radiol. 2021 Dec;94(1128):20210332.doi:10.1259/bjr.20210332.  

Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks | PLOS ONE  

Arnold DT, Donald C, Lyon M, Hamilton FW, Morley AJ, Attwood M, Dipper A, Barratt SL. Plos One. 2021 Apr 29;16(4):e0249607.doi:10.1371/journal.pone.0249607  

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet 

Recovery Collaborative group.  Lancet. 2021 May 29;397(10289):2049-2059. doi: 10.1016/S0140-6736(21)00897-7. Epub 2021 May 14  

A role for cardiopulmonary exercise testing in detecting physiological changes underlying health status in Idiopathic pulmonary fibrosis: a feasibility study | BMC Pulmonary Medicine | Full Text (biomedcentral.com) 

Davis R, Dixon C, Millar AB, Maskell NA, Barratt SL. BMC Pulm Med. 2021 May5;21(1):147.doi:10.1186/s12890-021-01520-8 

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID) | BMJ Open Respiratory Research 

Johnson SR, Jones MG, Khan F, Lawson R, Mehta P, Mitchell JA, Platé M, Poinasamy K, … BMJ Open Respir Res. 2021 Sep;8(1):e001049.doi:10.1136/bmjresp-2021-001049 

The burden of progressive fibrotic interstitial lung disease across the UK - PubMed (nih.gov) 

Simpson T, Barratt SL, Beirne P, Chaudhuri N, Crawshaw A, Crowley LE, Fletcher S, … Eur Respi J. 2021 Jul 8;58!):2100221.doi:10.1183/13993003.00221-2021  

High-frequency Ultrasound Assessment of Systemic Sclerosis Skin Involvement: Intraobserver Repeatability and Relationship With Clinician Assessment and Dermal Collagen Content | The Journal of Rheumatology (jrheum.org) 

Flower V, Barratt SL, Hart D, Mackenzie A, Shipley J, Ward S, Pauling JD. J Rheumatol. 2021 Jun; 48(6):867-876. doi: 10.3899/jrheum.200234  

Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study (bmj.com) 

Arnold DT, Attwood M, Barratt S, Elvers K, Morley A, McKernon J, Oates A, … Emerg Med J. 2021 Jul: emermed-2020-210380. Published online 2021 May 21. doi: 10.1136/emermed-2020-210380.  

Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services – DOAJ 

Barratt SL, Adamali HH, Cotton C, Mulhearn B, Iftikhar H, Pauling JD, Spencer L, … BMJ Open Respir Res. 2021 Jan;8(1):e000829. doi: 10.1136/bmjresp-2020-000829  

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort | Thorax (bmj.com)  

Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, … Thorax. 2020 Dec 3:thoraxjnl-2020-216086. doi: 10.1136/thoraxjnl-2020-216086 

High frequency ultrasound assessment of systemic sclerosis skin involvement: intra-observer repeatability and relationship with clinician assessment and dermal collagen content | The Journal of Rheumatology (jrheum.org) 

Flower VA, Barratt SL, Hart DJ, Mackenzie AB, Shipley JA, Ward SG, Pauling JD J Rheumatol. 2020 Nov 1: jrheum.200234. doi: 10.3899/jrheum.200234. 

Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study | Emergency Medicine Journal (bmj.com) 

Arnold DT, Attwood M, Barratt S, Elvers K, Morley A, McKernon J, Oates A, Donald C, … Emerg Med J. 2021 Jul: emermed-2020-210380. Published online 2021 May 21. doi: 10.1136/emermed-2020-210380. 

Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services – DOAJ 

Barratt SL, Adamali HH, Cotton C, Mulhearn B, Iftikhar H, Pauling JD, Spencer L, Adamali HI, … BMJ Open Respir Res. 2021 Jan;8(1):e000829. doi: 10.1136/bmjresp-2020-00082